GCM
MRTX

Glenview Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Glenview Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-203,800
Closed -$13.7M – 61
2022
Q2 		$13.7M Buy
203,800
+87,690
+76% +$5.89M 0.34% 39
2022
Q1 		$9.55M Buy
116,110
+70,310
+154% +$5.78M 0.19% 47
2021
Q4 		$6.72M Hold
45,800
– – 0.14% 49
2021
Q3 		$8.1M Buy
+45,800
New +$8.1M 0.15% 54